FORBAXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Forbaxin, and when can generic versions of Forbaxin launch?
Forbaxin is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in FORBAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Forbaxin
A generic version of FORBAXIN was approved as methocarbamol by PRINSTON INC on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FORBAXIN?
- What are the global sales for FORBAXIN?
- What is Average Wholesale Price for FORBAXIN?
Summary for FORBAXIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Patent Applications: | 3,585 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FORBAXIN at DailyMed |
![FORBAXIN drug patent expirations Drug patent expirations by year for FORBAXIN](/p/graph/s/t/FORBAXIN-patent-expirations.png)
US Patents and Regulatory Information for FORBAXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forest Labs | FORBAXIN | methocarbamol | TABLET;ORAL | 085136-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |